차세대 피임약 시장 : 세계 및 지역별 분석 - 성별, 오퍼링별, 최종사용자별, 지역별 - 분석과 예측(2024-2033년)

Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033

US $ 4,850 ￦ 7,007,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 10,113,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 차세대 피임약 시장에 대해 조사했으며, 시장의 개요와 성별, 오퍼링별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

주요 요약

제1장 시장 : 업계 전망

• 동향 : 현재 및 향후 영향 평가
• 공급망의 개요
• R&D 리뷰
• 규제 상황
• 시장 역학의 개요

제2장 차세대 피임약 시장(용도별)

• 용도 세분화
• 용도의 개요
• 세계의 차세대 피임약 시장, 성별
• 세계의 차세대 피임약 시장, 최종사용자별

제3장 차세대 피임약 시장, 제품 유형별

• 제품 세분화
• 제품 개요
• 세계의 차세대 피임약 시장, 오퍼링별

제4장 차세대 피임약 시장, 지역별

• 지역별 개요
• 촉진요인과 억제요인
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제5장 시장 - 경쟁 구도와 기업 개요

• 경쟁 구도
• 기업 개요
  • AbbVie
  • Bayer Corporation
  • Cooper Surgical, Inc.
  • Church & Dwight Co, Inc.
  • Merck & Co Inc.
  • Pfizer
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • The Female Health Company/Veru Inc.
  • Afaxys, Inc
  • Aditxt
  • Dare Bioscience, Inc
  • TherapeuticsMD, Inc
  • 기타 기업

제6장 조사 방법

KSA

영문 목차

영문목차

This report will be delivered in 7-10 working days.

The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.

The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.

Market Segmentation

Segmentation 1: by Gender

• Male
• Female

Segmentation 2: by by End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Channels
• Others

Segmentation 3: by Offering

• Drugs
• Devices

Segmentation 4: by Region

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America

Key Questions Answered:

• What are the major market drivers, challenges, and opportunities in the global next-generation contraceptives market and their case studies?
• How will the next-generation contraceptives market evolve and what is its scope in the future?
• What is the market share of the leading segments and sub-segments of the global next-generation contraceptives market?
• How will each segment of the global next-generation contraceptives market grow during the forecast period?
• What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1 Markets: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
• 1.2 Supply Chain Overview
  • 1.2.1 Value chain Analysis
  • 1.2.2 Market Map
• 1.3 R&D Review
  • 1.3.1 Patent Filing Trend by Country, by Company
• 1.4 Regulatory Landscape
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
  • 1.5.2 Market Restraints
  • 1.5.3 Market Opportunities

2 Next-Generation Contraceptives Market by Application

• 2.1 Application Segmentation
• 2.2 Application Summary
• 2.3 Global Next-Generation Contraceptives Market, by Gender
  • 2.3.1 Male
  • 2.3.2 Female
• 2.4 Global Next-Generation Contraceptives Market, by End User
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Channels
  • 2.4.4 Others

3 Next-Generation Contraceptives Market by Product Type

• 3.1 Product Segmentation
• 3.2 Product Summary
• 3.3 Global Next-Generation Contraceptives Market, by Offering
  • 3.3.1 Drugs
    • 3.3.1.1 Contraceptive Pills
    • 3.3.1.2 Injectables
    • 3.3.1.3 Patches
    • 3.3.1.4 Others
  • 3.3.2 Devices
    • 3.3.2.1 Condoms
    • 3.3.2.2 Vaginal Rings
    • 3.3.2.3 Intra-uterine Devices
    • 3.3.2.4 Others

4 Next-Generation Contraceptives Market by Region

• 4.1 Regional Summary
• 4.2 Drivers and Restraints as you go along...
• 4.3 North America
  • 4.3.1 Markets
    • 4.3.1.1 Key Market Participants in North America
    • 4.3.1.2 Business Drivers
    • 4.3.1.3 Business Challenges
  • 4.3.2 North America Next Generation Contraceptives Market, by End User
  • 4.3.3 North America by Country
    • 4.3.3.1 U.S.
    • 4.3.3.2 Canada
• 4.4 Europe
  • 4.4.1 Markets
    • 4.4.1.1 Key Market Participants in Europe
    • 4.4.1.2 Business Drivers
    • 4.4.1.3 Business Challenges
  • 4.4.2 Europe Next Generation Contraceptives Market, by End User
  • 4.4.3 Europe by Country
    • 4.4.3.1 U.K.
    • 4.4.3.2 Germany
    • 4.4.3.3 France
    • 4.4.3.4 Italy
    • 4.4.3.5 Spain
    • 4.4.3.6 Rest of Europe
• 4.5 Asia-Pacific
  • 4.5.1 Markets
    • 4.5.1.1 Key Market Participants in Asia-Pacific
    • 4.5.1.2 Business Drivers
    • 4.5.1.3 Business Challenges
  • 4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
  • 4.5.3 Asia-Pacific by Country
    • 4.5.3.1 China
    • 4.5.3.2 Japan
    • 4.5.3.3 India
    • 4.5.3.4 South Korea
    • 4.5.3.5 Rest of Asia-Pacific
• 4.6 Latin America
  • 4.6.1 Markets
    • 4.6.1.1 Key Market Participants in Latin America
    • 4.6.1.2 Business Drivers
    • 4.6.1.3 Business Challenges
  • 4.6.2 Latin America Next Generation Contraceptives Market, by End User
  • 4.6.3 Latin America by Country
    • 4.6.3.1 Brazil
    • 4.6.3.2 Mexico
    • 4.6.3.3 Rest of Latin America
• 4.7 Middle East and Africa
  • 4.7.1 Markets
    • 4.7.1.1 Key Market Participants in Middle East and Africa
    • 4.7.1.2 Business Drivers
    • 4.7.1.3 Business Challenges
  • 4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User

5 Markets - Competitive Landscape & Company Profiles

• 5.1 Competitive Landscape
• 5.2 Company Profiles
  • 5.2.1 AbbVie
    • 5.2.1.1 Company Overview
    • 5.2.1.2 Top Products / Product Portfolio
    • 5.2.1.3 Top Competitors
    • 5.2.1.4 Target Customers /End-Users
    • 5.2.1.5 Key Personnel
    • 5.2.1.6 Analyst View
  • 5.2.2 Bayer Corporation
    • 5.2.2.1 Company Overview
    • 5.2.2.2 Top Products / Product Portfolio
    • 5.2.2.3 Top Competitors
    • 5.2.2.4 Target Customers /End-Users
    • 5.2.2.5 Key Personnel
    • 5.2.2.6 Analyst View
  • 5.2.3 Cooper Surgical, Inc.
    • 5.2.3.1 Company Overview
    • 5.2.3.2 Top Products / Product Portfolio
    • 5.2.3.3 Top Competitors
    • 5.2.3.4 Target Customers /End-Users
    • 5.2.3.5 Key Personnel
    • 5.2.3.6 Analyst View
  • 5.2.4 Church & Dwight Co, Inc.
    • 5.2.4.1 Company Overview
    • 5.2.4.2 Top Products / Product Portfolio
    • 5.2.4.3 Top Competitors
    • 5.2.4.4 Target Customers /End-Users
    • 5.2.4.5 Key Personnel
    • 5.2.4.6 Analyst View
  • 5.2.5 Merck & Co Inc.
    • 5.2.5.1 Company Overview
    • 5.2.5.2 Top Products / Product Portfolio
    • 5.2.5.3 Top Competitors
    • 5.2.5.4 Target Customers /End-Users
    • 5.2.5.5 Key Personnel
    • 5.2.5.6 Analyst View
  • 5.2.6 Pfizer
    • 5.2.6.1 Company Overview
    • 5.2.6.2 Top Products / Product Portfolio
    • 5.2.6.3 Top Competitors
    • 5.2.6.4 Target Customers /End-Users
    • 5.2.6.5 Key Personnel
    • 5.2.6.6 Analyst View
  • 5.2.7 Reckitt Benckiser Group Plc
    • 5.2.7.1 Company Overview
    • 5.2.7.2 Top Products / Product Portfolio
    • 5.2.7.3 Top Competitors
    • 5.2.7.4 Target Customers /End-Users
    • 5.2.7.5 Key Personnel
    • 5.2.7.6 Analyst View
  • 5.2.8 Teva Pharmaceuticals Industries Ltd.
    • 5.2.8.1 Company Overview
    • 5.2.8.2 Top Products / Product Portfolio
    • 5.2.8.3 Top Competitors
    • 5.2.8.4 Target Customers /End-Users
    • 5.2.8.5 Key Personnel
    • 5.2.8.6 Analyst View
  • 5.2.9 The Female Health Company/Veru Inc.
    • 5.2.9.1 Company Overview
    • 5.2.9.2 Top Products / Product Portfolio
    • 5.2.9.3 Top Competitors
    • 5.2.9.4 Target Customers /End-Users
    • 5.2.9.5 Key Personnel
    • 5.2.9.6 Analyst View
  • 5.2.10 Afaxys, Inc
    • 5.2.10.1 Company Overview
    • 5.2.10.2 Top Products / Product Portfolio
    • 5.2.10.3 Top Competitors
    • 5.2.10.4 Target Customers /End-Users
    • 5.2.10.5 Key Personnel
    • 5.2.10.6 Analyst View
  • 5.2.11 Aditxt
    • 5.2.11.1 Company Overview
    • 5.2.11.2 Top Products / Product Portfolio
    • 5.2.11.3 Top Competitors
    • 5.2.11.4 Target Customers /End-Users
    • 5.2.11.5 Key Personnel
    • 5.2.11.6 Analyst View
  • 5.2.12 Dare Bioscience, Inc
    • 5.2.12.1 Company Overview
    • 5.2.12.2 Top Products / Product Portfolio
    • 5.2.12.3 Top Competitors
    • 5.2.12.4 Target Customers /End-Users
    • 5.2.12.5 Key Personnel
    • 5.2.12.6 Analyst View
  • 5.2.13 TherapeuticsMD, Inc
    • 5.2.13.1 Company Overview
    • 5.2.13.2 Top Products / Product Portfolio
    • 5.2.13.3 Top Competitors
    • 5.2.13.4 Target Customers /End-Users
    • 5.2.13.5 Key Personnel
    • 5.2.13.6 Analyst View
  • 5.2.14 Other Companies

6 Research Methodology

관련자료